gliclazide has been researched along with Lymph Node Metastasis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, D; Cao, X; Hou, Z; Jia, Z; Jiang, J; Oshima, M; Suo, Y; Tsukamoto, T; Wen, S; Wu, Y; You, L; Zhang, H | 1 |
1 other study(ies) available for gliclazide and Lymph Node Metastasis
| Article | Year |
|---|---|
18β-glycyrrhetinic acid suppresses gastric cancer by activation of miR-149-3p-Wnt-1 signaling.
Topics: Adult; Aged; Animals; Apoptosis; Cell Line, Tumor; Cyclooxygenase 2; Female; Glycyrrhetinic Acid; Humans; Lymphatic Metastasis; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Middle Aged; Stomach Neoplasms; Wnt Signaling Pathway; Wnt1 Protein | 2016 |